BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27494729)

  • 1. An anterior left ventricular lead position is associated with increased mortality and non-response in cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Riahi S; Petersen HH; Haarbo J; Jørgensen OD; Nielsen JC
    Int J Cardiol; 2016 Nov; 222():157-162. PubMed ID: 27494729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Haarbo J; Riahi S; Philbert BT; Jørgensen OD; Nielsen JC
    Europace; 2018 Sep; 20(9):e133-e139. PubMed ID: 29036292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between right ventricular lead position and clinical outcomes in patients with cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Riahi S; Petersen HH; Haarbo J; Jørgensen OD; Nielsen JC
    Europace; 2018 Apr; 20(4):629-635. PubMed ID: 28340014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of left ventricular pacing site on cardiac resynchronization therapy outcome and mortality: the results of a PROSPECT substudy.
    Mortensen PT; Herre JM; Chung ES; Bax JJ; Gerritse B; Kruijshoop M; Murillo J
    Europace; 2010 Dec; 12(12):1750-6. PubMed ID: 20852290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing.
    Leyva F; Zegard A; Taylor RJ; Foley PWX; Umar F; Patel K; Panting J; van Dam P; Prinzen FW; Marshall H; Qiu T
    J Am Heart Assoc; 2018 Aug; 7(16):e008508. PubMed ID: 30369313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
    Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
    Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biventricular paced QRS predictors of left ventricular lead locations in relation to mortality in cardiac resynchronization therapy.
    Fontaine JM; Gupta A; Franklin SM; Kang CU; Whigham LA
    J Electrocardiol; 2015; 48(2):226-35. PubMed ID: 25552478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients.
    Kutyifa V; Kosztin A; Klein HU; Biton Y; Nagy VK; Solomon SD; McNitt S; Zareba W; Goldenberg I; Roka A; Moss AJ; Merkely B; Singh JP
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1410-1420. PubMed ID: 30466845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Sommer A; Kronborg MB; Nørgaard BL; Poulsen SH; Bouchelouche K; Böttcher M; Jensen HK; Jensen JM; Kristensen J; Gerdes C; Mortensen PT; Nielsen JC
    Eur J Heart Fail; 2016 Nov; 18(11):1365-1374. PubMed ID: 27087019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: A feature-tracking and contrast-enhanced cardiovascular magnetic resonance study.
    Taylor RJ; Umar F; Panting JR; Stegemann B; Leyva F
    Heart Rhythm; 2016 Feb; 13(2):481-9. PubMed ID: 26498258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
    Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
    J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar left ventricular pacing is associated with significant reduction in heart failure or death in CRT-D patients with LBBB.
    Jamé S; Kutyifa V; Aktas MK; McNitt S; Polonsky B; Al-Ahmad A; Zareba W; Moss A; Wang PJ
    Heart Rhythm; 2016 Jul; 13(7):1468-74. PubMed ID: 26961303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy when no lateral pacing option exists: vectorcardiographic guided non-lateral left ventricular lead placement predicts acute hemodynamic response.
    Ross S; Odland HH; Aranda A; Edvardsen T; Gammelsrud LO; Haland TF; Cornelussen R; Hopp E; Kongsgaard E
    Europace; 2018 Aug; 20(8):1294-1302. PubMed ID: 29036446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular regional remodeling and lead position during cardiac resynchronization therapy.
    Kronborg MB; Sommer A; Fyenbo DB; Norgaard BL; Gerdes C; Jensen JM; Jensen HK; Kristensen J; Nielsen JC
    Heart Rhythm; 2018 Oct; 15(10):1542-1549. PubMed ID: 29678780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right ventricular lead location, right-left ventricular lead interaction, and long-term outcomes in cardiac resynchronization therapy patients.
    Daimee UA; Klein HU; Giudici MC; Zareba W; McNitt S; Polonsky B; Moss AJ; Kutyifa V
    J Interv Card Electrophysiol; 2018 Jul; 52(2):185-194. PubMed ID: 29572715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.